Your browser doesn't support javascript.
loading
Concurrent validity between field tests and cardiopulmonary exercise testing in patients with idiopathic pulmonary fibrosis.
Pereira, Hugo Leonardo Alves; Mancuzo, Eliane Viana; Ribeiro-Samora, Giane Amorim; Albuquerque Pataro, Anna Clara; Dos Reis Estrella, Deborah; Pereira, Danielle Aparecida Gomes; Parreira, Verônica Franco.
Afiliação
  • Pereira HLA; Rehabilitation Sciences Program, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
  • Mancuzo EV; Department of Medical Clinic, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
  • Ribeiro-Samora GA; Visiting Professor at Physiotherapy Program, Universidade Federal do Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil.
  • Albuquerque Pataro AC; Department of Physiotherapy - Undergraduate student, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
  • Dos Reis Estrella D; Sciences Applied to Adult Health Care Program, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
  • Pereira DAG; Department of Physiotherapy, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
  • Parreira VF; Department of Physiotherapy, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Physiother Theory Pract ; : 1-9, 2024 Apr 11.
Article em En | MEDLINE | ID: mdl-38602319
ABSTRACT

BACKGROUND:

Maximal treadmill cardiopulmonary exercise testing is the gold standard for assessing functional capacity in patients with idiopathic pulmonary fibrosis (IPF).

PURPOSE:

Primarily to investigate the concurrent validity between three field tests and cardiopulmonary exercise testing in these patients.

METHODS:

Patients performed the cardiopulmonary exercise testing, a six-minute walk test, an incremental shuttle walk test, and, the Glittre-ADL test. For cardiopulmonary exercise testing, the ten seconds with the higher average of the peak oxygen uptake obtained within the last 30 seconds were considered; for six-minute walk test and incremental shuttle walk test, the longer distance; and for the Glittre-ADL test, the shorter time spent. Concurrent validity was assessed using different regression models based on the best adjustment of the data.

RESULTS:

Twenty-two patients with IPF were assessed, aged 68 ± 8.1 years, 13 male. Patients presented a peak oxygen uptake of 16.5 ± 3.6 mL.kg-1.min1, achieving a distance of 512.6 ± 102.8 meters in the six-minute walk test and 415.7 ± 125.1 meters in incremental shuttle walk test. The walking distance in the six-minute walk test and the incremental shuttle walk test explained, respectively, 64% and 56% peak oxygen uptake variance observed in the cardiopulmonary exercise testing (R2 = 0.64,p < .001; R2 = 0.56,p < .001). The time spent in the Glittre-ADL test was 233.4 ± 88.7 seconds and explained 47% of the peak oxygen uptake variance observed in cardiopulmonary exercise testing (R2 = 0.47,p = .001).

CONCLUSION:

The six-minute walk test, incremental shuttle walk test, and Glittre-ADL test were considered valid tests to explain the peak oxygen uptake variance obtained by the cardiopulmonary exercise testing in patients with IPF.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article